SCM
QTTB icon

Sio Capital Management’s Q32 Bio QTTB Stock Holding History

Sio Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-697,413
Closed -$2.4M – 64
2024
Q4 		$2.4M Buy
+697,413
New +$22M 0.68% 32

Other funds holding QTTB

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Sio Capital Management's QTTB Position: Q1 2025 in Review

Sio Capital Management sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 697,413 shares — an estimated $2.4M sold.

Sio Capital Management first reported a position in QTTB in Q4 2024 and held it in 1 quarter. The position peaked at $2.4M in Q4 2024. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Sio Capital Management reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Sio Capital Management sold 697,413 Q32 Bio shares in Q1 2025, an estimated $2.4M.
  • Sio Capital Management first reported a position in Q32 Bio in Q4 2024 and held it in 1 quarter.
  • Sio Capital Management's Q32 Bio position peaked at $2.4M in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Sio Capital Management's 13F filing for Q1 2025, filed 15 May 2025.